US 11807674
Hepcidin analogues and uses thereof
granted A61KA61K38/00A61P
Quick answer
US patent 11807674 (Hepcidin analogues and uses thereof) held by Protagonist Therapeutics, Inc. expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Protagonist Therapeutics, Inc.
- Grant date
- Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K38/00, A61P, A61P3/00, A61P3/12